We are excited to have supported this new study via our #LongCovid Research Consortium. The project team are our incredible @CUBoulderBN colleagues at the University of Colorado Boulder: polybio.org/multiple-hit-m…
2/ The findings suggest that multiple infectious “hits” (#viral and #bacterial) may amplify long-term neuroinflammatory or neuroimmune symptoms in patients with #LongCovid.
3/ More specifically, the team showed that brain exposure to a #SARS-CoV-2 spike protein subunit drove a long-term vulnerability not only to #neuroinflammation, but also to forms of autonomic dysregulation such as increased heart rate and core body temperature.
4/ The research – conducted in rats – also found that S1 protein induced a considerable decrease in cortisol hormone levels in a #brain region called the hippocampus. This process may be related to some teams’ findings of low cortisol #hormone levels in patients with LongCovid.
5/ Neuroimmune ‘priming’ is an effect by which subsequent #immune challenges – such as several infections in a row – can cause increasingly profound and protracted #neuroinflammation,” said PolyBio co-founder and neuroimmunologist Dr. Michael VanElzakker.
6/ This means that multiple inflammatory challenges can add up to be greater than the sum of their parts.
7/ While this group used LPS which is the part of #bacteria that drives inflammation, the phenomenon of priming also relates to other, non-infectious inflammatory challenges such as a concussion.”
8/ The findings suggest that treatment protocols identifying and addressing different #infectious or #inflammatory insults in patients with long COVID or related conditions may be needed to manage symptoms.
9/ They also show that problems like #autonomic dysfunction and #hormonal imbalances in long Covid can be directly connected to #environmental insults and exposures.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Breaking!: Research published today in Science Translational Medicine and supported by PolyBio Research Foundation shows that the #SARS-CoV-2 virus can chronically persist in the gut of patients with long COVID for over 2 years: polybio.org/chronic-virus-…
2/ The findings, published by a UCSF team known for innovation in HIV research, also documented T cell immune activation across the bodies and brains of people after COVID. This T cell activation was particularly elevated in the spinal cord and gut wall of long COVID participants
3/ Long COVID is not a mystery” says UCSF's Michael Peluso MD, who co-led the study. “Our findings provide clear evidence of #virus persistence and sustained immune activation after #COVID-19. We must use this information to test treatments that might get people better.”
We are proud to have supported this new paper published in @BrainBehavImm.
Led by @MBVanElzakker & team at @MGHMartinos, it is the is first study to document neuroinflammation in the long COVID brain along with evidence of vascular problems: polybio.org/longcovid-brai…
2/ Neuroinflammation was located in some #brain areas that are exposed to circulating blood factors via gaps in the “blood-brain barrier” of the brain’s blood vessels.
3/ This compelled the researchers to measure a selection of blood factors related to #vascular health or damage.
They found that six such factors showed a correlation with the neuroinflammation signal in the brains of the long COVID study participants.
Great to see this new piece in @ScienceMagazine highlighting LongCovid clinical trials working to target #SARS-CoV-2 persistence. We are proud to be supporting nearly all the teams/trials mentioned in the piece via our LongCovid Research Consortium: science.org/content/articl…
2/ They include the trial at Sinai where @PutrinoLab , @polybio’s Dr. Amy Proal and Akiko Iwasaki’s group at Yale “will study two broad-spectrum antivirals that don’t require viral replication to work: Truvada and Selzentry, both approved for HIV”: polybio.org/projects/a-cli…
@PutrinoLab @polybio 3/ Also the trial in #LongCovid children where @LaelYonker and team are working to determine if Lorazotide can tighten cellular junctions in the #gut lining and stop SARS-CoV-2 spike protein from entering the blood: polybio.org/projects/sars-…
We are excited to announce a 2nd series of collaborative projects & clinical trials supported via our LongCovid Research Consortium: polybio.org/new-longcovid-…
2/ The projects/trials further address #SARS-CoV-2 persistence in #LongCOVID, plus the impact of viral activity on #Alzheimer’s & cardiovascular disease. They include:
1. Icahn School of Medicine Mount Sinai: “A clinical trial of repurposed HIV antivirals in LongCOVID” 👉 Learn more here: polybio.org/projects/a-cli…
PolyBio is glad to have supported this Nature Immunology paper showing #LongCovid immune dysregulation connected to potential #SARS-CoV-2 tissue reservoirs. Learn more about the findings here: polybio.org/polybio-suppor…
2/ Overall, Long COVID patients showed differences in the distributions of their T cells, implying ongoing #immune responses. The team also documented a mis-coordination between the SARS-CoV-2-specific T and B cell responses of Long COVID patients.
3/ What underlies the T and B cell dysfunction identified in the study? Data point to the possibility that persistent #SARS-CoV-2 reservoirs in patient tissue are a contributing factor.
We are excited to announce a $15M gift from Kanro: a philanthropic fund to support scientific research established by Vitalik Buterin, co-founder of Ethereum: finance.yahoo.com/news/polybio-r…
2/ The funding will support a second phase of research and clinical trials via the #LongCovid Research Consortium (LCRC): a global scientific collaboration to rapidly and openly study core biological drivers of Long COVID: polybio.org/longcovid
3/ This is Buterin's second $15M gift to the Consortium and will allow dozens of new projects to move forward. The focus will be the continued study and treatment of #SARS-CoV-2 persistence as a driver of LongCovid.